Question

What

are the considerations for this drug created for Mila? Does it
fulfill more of consequentialist/utilitarian perspective or more of
a deontological perspective?
A new drug, created to treat just one patient, has pushed the bounds of personalized medicine and has raised Milasen is believed to be the first drug developed for a single patient (CAR-T cancer thera

Answer 1

Considerations for the drug created for Mila from consequentialist/utilitarian and deontological perspectives.

Step-by-step explanation:

The development of a drug for a single patient, such as Mila, raises considerations from both a consequentialist/utilitarian perspective and a deontological perspective.

From a consequentialist/utilitarian perspective, the main consideration would be to assess the overall consequences and happiness produced by the drug. This would involve evaluating whether the drug provides a significant improvement in Mila's health and quality of life, and whether it could potentially benefit other patients in the future.

On the other hand, from a deontological perspective, the focus would be on ethical principles and duties. This would involve considering whether the drug respects the dignity and autonomy of the patient, and whether it adheres to ethical guidelines for human research subjects.